Search

Your search keyword '"ABACAVIR"' showing total 3,652 results

Search Constraints

Start Over You searched for: Descriptor "ABACAVIR" Remove constraint Descriptor: "ABACAVIR"
3,652 results on '"ABACAVIR"'

Search Results

10. A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1.

11. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1.

13. Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study

14. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

15. Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study.

16. Antiretroviral Drug Repositioning for Glioblastoma.

17. The anti-HIV drug abacavir stimulates β-catenin activity in osteoblast lineage cells.

18. Molecularly imprinted polymers as solid-phase and dispersive solid-phase extraction sorbents in the extraction of antiretroviral drugs in water: adsorption, selectivity and reusability studies

21. Molecularly imprinted polymers as solid-phase and dispersive solid-phase extraction sorbents in the extraction of antiretroviral drugs in water: adsorption, selectivity and reusability studies.

22. Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer.

24. Role of the NO-GC/cGMP signaling pathway in platelet biomechanics.

25. Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands.

27. Comparison of electrochemical and chemical approaches to forced oxidative degradation studies: Abacavir case study

29. A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1.

30. Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.

31. ANALYSIS OF ABACAVIR LAMIVUDINE AND ZIDOVUDINE BY SPECTROPHOTOMETRIC METHOD IN TRIPLE MIXTURE.

32. Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens.

Catalog

Books, media, physical & digital resources